In a study published online by JAMA Cardiology, Marco Valgimigli, M.D., Ph.D., of Bern University Hospital, Bern, Switzerland, and colleagues assessed the efficacy and safety of prolonged (24 months) ...
New System Provides an Easy to Use, Accurate and Controlled, One-Handed Stent Delivery System When Treating Patients with Peripheral Arterial Disease DUBLIN, Medtronic plc today announced the launch ...
Please provide your email address to receive an email when new articles are posted on . The FDA recently approved a self-expanding peripheral stent system for use in the common iliac, external iliac, ...
BLOOMINGTON, Indiana — Following the advice of its advisory panel, the Food and Drug Administration has approved the Zilver PTX paclitaxel-eluting peripheral stent (Cook Medical, Bloomington, IN) for ...
NATICK, Mass., Launching a key clinical trial expected to serve as the foundation for global regulatory approvals, a physician in Auckland, New Zealand has performed the first patient implant of the ...
Please provide your email address to receive an email when new articles are posted on . HOLLYWOOD, Fla. — The optimal treatment for in-stent restenosis in the peripheral arteries depends on lesion ...
The global peripheral vascular devices market is experiencing steady growth, driven by rising incidences of cardiovascular diseases and an aging population. Advances in minimally invasive technologies ...
Reserachers assessed the efficacy and safety of prolonged (24 months) vs short (6 months or less) dual antiplatelet therapy in patients with peripheral arterial disease undergoing percutaneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results